MDAI

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Retrieved on: 
Friday, May 26, 2023

MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.

Key Points: 
  • MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.
  • Historically, MDMA has only been developed as a single salt and the crystal structures of its enantiomers had not been characterized.
  • As previously reported, Terran found that the S enantiomer of MDEA had significant advantages over the (R)-MDEA in preclinical models.
  • Terran is also developing the S enantiomer of MBDB which was shown to have significant advantages over (R)-MBDB in preclinical models.

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Retrieved on: 
Thursday, May 11, 2023

The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.

Key Points: 
  • The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.
  • Terran believes that therapeutic options for patients should be equally diverse, with unique psychedelics and empathogens tailored to specific patient needs.
  • Terran completed what is believed to be the first comprehensive salt and polymorph screen performed to date on this compound.
  • Terran completed additional improvements including the synthesis of deuterated forms of racemic methylone, R-methylone, and S-methylone with improved pharmacokinetics.

Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I

Retrieved on: 
Tuesday, April 11, 2023

Upon completion of the Transaction, the Combined Company expects to operate under the expected name Spectral AI and to be listed on Nasdaq under the symbol MDAI.

Key Points: 
  • Upon completion of the Transaction, the Combined Company expects to operate under the expected name Spectral AI and to be listed on Nasdaq under the symbol MDAI.
  • Wensheng Fan, Chief Executive Officer of Spectral MD, said: “This transaction is an excellent strategic move for Spectral MD.
  • The Rosecliff team has done its work and we believe Spectral MD to be a leading AI-driven and disruptive healthcare platform.
  • The proposed Transaction is expected to deliver gross proceeds to Spectral MD in excess of $20 million (assuming no redemptions).

Marvion's HKU Campusland scores well with undergraduates and is expected to extend its meta-campus to primary and secondary school students later this year

Retrieved on: 
Thursday, March 2, 2023

As such, Marvion will be looking to roll out the meta-campus to primary and secondary schools this year.

Key Points: 
  • As such, Marvion will be looking to roll out the meta-campus to primary and secondary schools this year.
  • The platform which first had its initial rollout prioritizing students in the Faculty of Science at HKU, received rave reviews and now expanding its reach to include secondary school students in Hong Kong.
  • Plans are in place for junior students to participate in HKU Campusland in Spring and Summer 2023.
  • Dr. Adela Lau, Deputy Director of HKU SAAS Data Science, commented on the positive impact of HKU Campusland on students, "Students were excited and enjoyed interacting in HKU Campusland."

Marvion unveiling HKU CampusLand - a joint metaverse initiative with Marvel Digital AI and the University of Hong Kong

Retrieved on: 
Thursday, October 20, 2022

SINGAPORE, Oct. 20, 2022 /PRNewswire/ -- Metaverse media company Marvion, a wholly owned subsidiary of Bonanza Goldfields Corp. (OTC:BONZ)  is pleased to unveil HKU CampusLand – a joint initiative with Marvel Digital AI (MDAI) and the Department of Statistics and Actuarial Science of HKU.

Key Points: 
  • SINGAPORE, Oct. 20, 2022 /PRNewswire/ -- Metaverse media company Marvion, a wholly owned subsidiary of Bonanza Goldfields Corp. (OTC:BONZ)is pleased to unveil HKU CampusLand a joint initiative with Marvel Digital AI (MDAI) and the Department of Statistics and Actuarial Science of HKU.
  • As the first metaverse campus with artificial intelligence among Hong Kong's higher education institutions HKU CampusLand was developed on the Roblox platform and officially launched on 17 Oct 2022.
  • Commenting on HKU CampusLand, Dr Patrick Ma, CEO of MDAi, said, "This is a perfect example to showcase the potential of the metaverse in the field of education.
  • In addition, our HKU CampusLand is very different as our digital human avatars are powered by artificial intelligence.